Mystery solved! Meet Dr. David Raleigh, one of the brilliant UCSF researchers we champion. To cap off May’s Brain Tumor Awareness Month, Meningioma Mommas delivered a fresh $5,000 grant to his lab—officially pushing our lifetime support for UCSF meningioma research to a massive $65,000! Because Dr. Raleigh is working around the clock saving lives and…
Now that the MLB season has officially launched, we are stepping up to the plate for our vital mission: Striking out meningioma brain tumors once and for all! We are pitching in to raise $50,000 for our MVP researcher, Dr. Long-Sheng Chang. With NIH funding being cut, Dr. Chang needs our lineup to stay in…
Striking Out Meningiomas: Batter Up Campaign Update… Thanks to your tremendous support, we’re thrilled to award an initial grant of $10,000 to Dr. Hiro Wakimoto, MD, PhD, Associate Professor of Neurosurgery at Harvard Medical School and Investigator at Massachusetts General Hospital, and his groundbreaking research lab. This is a crucial “first pitch” in our journey…
Batter Up! ⚾️ With baseball season in full swing, let’s channel that energy into our vital mission: Striking out meningioma brain tumors, once and for all! This season, Meningioma Mommas is pitching in for critical research for more effective treatments and, ultimately, a cure for meningiomas. Meningiomas are the most common primary brain tumor, yet…
Meningioma Mommas is continuing its longtime collaboration with Harvard researcher, Dr. Hiro Wakimoto by awarding him a $7,500 grant for the next phase of his Photo-Dynamic Oncolytic Virus Therapy research, which has revealed promising results in the treatment of meningioma brain tumors. “This work showed for the first time that our genetically engineered virus therapy…
Meningioma Mommas has awarded Harvard researcher, Dr. Hiro Wakimoto a $5,000 grant to advance his team’s photodynamic therapy research. Dr. Wakimoto shares the following encouraging updates: “We have been particularly interested in the potential power of an engineered virus–to be specific, genetically engineered herpes simplex virus–to act as an agent able to kill cancer cells…
Meningioma Mommas has been hard at work behind the scenes during these unprecedented and challenging times to ensure ongoing critical research. We are grateful for our generous second family supporters for making these grants possible. We are pleased to announce that Dr. Nader Sanai, Director of the Ivy Brain Tumor Center at the Barrow Neurological…
New York University neurosurgeon and researcher, Dr. Nader Delavari, is dedicating his research project, “Enzymatic Modification of the Consistency of Firm Tumors may Facilitate their Safe Resection” to Meningioma Mommas member, Debbie Arnold Burnett, who lost her 21-year-meningioma battle on June 22, 2020. Debbie joined Meningioma Mommas in 2003 and freely shared her battle to treat…
Meningioma Mommas has awarded a second grant for $10,000 to Harvard researchers, Dr. Hiroaki Wakimoto and Dr. Robert Martuza for their project, “How to Best Activate Anti-tumor Immune Cells Triggered by Oncolytic Herpes Simplex Viruses (oHSVs) to Attack and Destroy High Grade Meningiomas”. This is phase one of their project and Meningioma Mommas is diligently…
Meningioma Mommas has awarded a $29,042 grant to University of Colorado researchers, Dr. Kevin Lillehei, Dr. Michael Graner, Dr. Philip Tatman and their support team (Team Colorado!) to continue their focus on, “Pre-clinical trial evaluation of HDAC inhibitors for the treatment of meningiomas.” Project Summary: Meningiomas are a common primary brain tumor, accounting for 36% of…